Search

everythinglearnresearchcommunity

for

Search:↓

The document's content cannot be summarized because it is not accessible or understandable.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Inflammation damages sweat ducts, causing sweat gland injury.

The workshop promoted better medicine use and health practices through global collaboration.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Italian hair restoration surgeons had their first meeting in Rome.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The author found the Dermatology Nurses’ Association’s annual meeting valuable for both learning and making friends.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib treatment is used for teenagers with alopecia areata.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Baricitinib may effectively treat oral lichen planus.

The VII International Congress of Dermocaribe in Colombia was a major dermatology event with over 50 lectures on various skin conditions and treatments.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.